At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02566 JIUYUAN GENE
Not Yet Opened 01-21 15:59:34
9.380
+0.210
+2.29%
High9.500
Low9.080
Vol338.40K
Open9.150
D1 Closing9.170
Amplitude4.58%
Mkt Cap2.30B
Tradable Cap1.02B
Total Shares245.00M
T/O3.17M
T/O Rate0.31%
Tradable Shares109.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JIUYUAN GENE (02566) Repurchases 205,400 Shares for Approximately HK$1.9277 Million on January 21
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd, formerly Hangzhou Jiuyuan Gene Engineering Co Ltd, is a China-based company principally engaged in the research, development, manufacturing and commercialization of biopharmaceutical products and medical devices. The Company focuses on orthopedics, metabolic diseases, oncology and blood treatment. The Company's orthopedic products include Guyoudao bone repair materials. The Company's oncology products include Jilifen, Jijufen, Jiouting, Jifuwei, and Jitansu. The Company's blood products include Jipailin and Yinuojia. The Company's products are mainly used to treat diseases such as diabetes, multiple myeloma, thrombocytopenia, and neutropenia. The Company mainly operates its businesses in the domestic and overseas markets.